DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 9, 2014
April 28, 2020
712ebdd8-de0d-4a6d-b6c3-0983093ca377
Related Documents
Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs — General Considerations
Guidance DocumentMarch 18, 2014Center for Drug Evaluation and Research
Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act
Guidance DocumentJuly 11, 2014Center for Drug Evaluation and Research
Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers: Questions and Answers Guidance for Industry
Guidance DocumentJanuary 10, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox